{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:00:32Z","timestamp":1790719232970,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jhep.2014.06.027","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T01:00:46Z","timestamp":1404954046000},"page":"994-1003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest\u00ae) and elastography (FibroScan\u00ae)"],"prefix":"10.1016","volume":"61","author":[{"given":"Thierry","family":"Poynard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Vergniol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Foucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Munteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassil","family":"Merrouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Lebray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Rudler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Deckmyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Perazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Thabut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Ratziu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"de Ledinghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.06.027_b0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.027_b0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases","volume":"47","author":"Goodman","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.027_b0015","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis","volume":"51","author":"Garcia-Tsao","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.027_b0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(03)00171-5","article-title":"Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B","volume":"39","author":"Myers","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.027_b0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study","volume":"55","author":"Foucher","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.06.027_b0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/liv.12393","article-title":"Hepatitis B: are non-invasive markers of liver fibrosis reliable?","volume":"34","author":"Castera","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2014.06.027_b0035","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ajg.2014.21","article-title":"Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis","volume":"109","author":"Salkic","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.06.027_b0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11901-011-0096-0","article-title":"Noninvasive markers of hepatic fibrosis in chronic hepatitis B","volume":"10","author":"Poynard","year":"2011","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.jhep.2014.06.027_b0045","doi-asserted-by":"crossref","first-page":"e44930","DOI":"10.1371\/journal.pone.0044930","article-title":"Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis","volume":"7","author":"Chon","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.06.027_b0050","doi-asserted-by":"crossref","first-page":"e2573","DOI":"10.1371\/journal.pone.0002573","article-title":"An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest\u2122-ActiTest) and viral load","volume":"3","author":"Ngo","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.06.027_b0055","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3851\/IMP1570","article-title":"Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies","volume":"15","author":"Poynard","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2014.06.027_b0060","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2036.2010.04547.x","article-title":"Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers","volume":"33","author":"Cast\u00e9ra","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2014.06.027_b0065","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jhep.2012.04.025","article-title":"Validation of liver fibrosis biomarker (FibroTest\u2122) for assessing liver fibrosis progression: proof of concept and first application in a large population","volume":"57","author":"Poynard","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.027_b0070","first-page":"445","article-title":"Prognostic value of liver fibrosis biomarkers: a meta-analysis","volume":"7","author":"Poynard","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.jhep.2014.06.027_b0075","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/apt.12307","article-title":"Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus","volume":"37","author":"de L\u00e9dinghen","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2014.06.027_b0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.25937","article-title":"Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy","volume":"57","author":"Lai","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.027_b0085","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2013.11.016","article-title":"Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest\u2122) and transient elastography (FibroScan\u00ae)","volume":"60","author":"Poynard","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.027_b0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2013.05.015","article-title":"Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C","volume":"59","author":"Poynard","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.027_b0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-230X-11-39","article-title":"Applicability and precautions of use of liver injury biomarker FibroTest\u2122. A reappraisal at 7years of age","volume":"11","author":"Poynard","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2014.06.027_b0100","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.23425","article-title":"Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations","volume":"51","author":"Cast\u00e9ra","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.027_b0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cgh.2013.04.036","article-title":"Management of hepatitis B: our practice and how it relates to the guidelines","volume":"12","author":"Yapali","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.06.027_b0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/apt.12590","article-title":"Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase guidet\u2a7d40IU\/L and significant hepatic fibrosis","volume":"39","author":"Chao","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2014.06.027_b0115","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.cgh.2012.01.023","article-title":"Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis","volume":"10","author":"Poynard","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.06.027_b0120","series-title":"NCSS 8","author":"Hintze","year":"2012"},{"key":"10.1016\/j.jhep.2014.06.027_b0125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/MCG.0b013e31825079f1","article-title":"The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B","volume":"46","author":"Chon","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2014.06.027_b0130","doi-asserted-by":"crossref","first-page":"e35825","DOI":"10.1371\/journal.pone.0035825","article-title":"Prospective validation of FibroTest\u2122 in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.06.027_b0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/liv.12003","article-title":"Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease","volume":"33","author":"Shi","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2014.06.027_b0140","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1440-1746.2012.07132.x","article-title":"Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus-related cirrhosis","volume":"27","author":"Wang","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.06.027_b0145","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/j.gastro.2013.02.002","article-title":"Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment","volume":"144","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.027_b0150","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2014.06.027_b0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag","year":"2003","journal-title":"Gastroenterology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814004577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814004577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T14:42:57Z","timestamp":1746283377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814004577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0168827814004577"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.06.027","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718489171.793497420","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest\u00ae) and elastography (FibroScan\u00ae)","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}